Comprehensive solutions across the inhalation product lifecycle, ensuring efficiency, quality, and regulatory compliance.
- Contract Manufacturing (CDMO) – Premix | Bulk Capsules | FDF (With/Without Device).
Flexible, compliant Contract Development and Manufacturing Organization (CDMO) solutions for global markets, including premix, bulk capsules, and finished dosage forms with or without device integration.
- Product Development (CRO) – Generics & Novel Products.
End-to-end product development for generic and differentiated formulations, our contract research organisation (CRO) service is tailored for highly regulated markets like US and EU.
- Technology Transfer – Scale-Up & Commercialisation.
Seamless technology transfer from lab to market of inhalation portfolio, ensuring validated scale-up, regulatory support, and commercial readiness.
Our Offerings
Our mission is to provide the highest standard of pulmonary therapy related solutions.
1. Contract Manufacturing (CDMO)
As a leading Contract Development and Manufacturing Organization (CDMO), we deliver flexible, scalable, and regulatory-compliant manufacturing solutions.
Our specialized offerings include:
- Premix Manufacturing – development and supply of high-quality premix formulations aligned with IP, BP, and global pharmacopoeial standards.
- Bulk Capsules – large-scale manufacturing of bulk capsule formulations under certified facility, ensuring consistency and compliance.
- Finished Dosage Forms (FDF) – manufactured in two options to meet diverse partner requirements:
- With Device (Drug–Device Combination Products) – integrated solutions that combine capsules with inhalation or other delivery devices, enhancing usability and patient outcomes.
- Without Device (Standalone Dosage Forms) – flexible supply of finished dosage forms ready for global markets without device integration.
Our manufacturing facilities are fully equipped to serve highly regulated markets like US and Europe, ensuring global reliability and compliance.
2. Product Development (CRO)
We support partners with end-to-end product development expertise across therapeutic categories.
Services include:
- Generic Product Development – efficient development of cost-competitive generics designed for US FDA, EU EMA, and global filings.
- Novel & Differentiated Products – innovative formulations and advanced delivery systems that offer value-added differentiation.
- Global Market Compliance – proven track record in preparing regulatory submissions for highly regulated markets worldwide.
Our R&D and formulation teams leverage strong CMC frameworks to accelerate product approvals and commercialization.
3. Technology Transfer
We ensure seamless technology transfer from R&D to full-scale commercial manufacturing, enabling rapid global market access.
- Scale-Up & Validation – reproducible, validated processes with focus on quality and efficiency.
- Regulatory Support – comprehensive technical documentation for international filings.
- Commercial Supply Integration – smooth transition into global manufacturing networks with consistent product performance.
Our structured tech transfer protocols minimize risks, reduce timelines, and guarantee compliance with international regulatory standards.